QQQ   431.84 (+0.18%)
AAPL   169.78 (-1.69%)
MSFT   416.30 (+0.64%)
META   503.26 (+0.61%)
GOOGL   154.79 (-0.05%)
AMZN   184.04 (+0.23%)
TSLA   157.27 (-2.61%)
NVDA   871.25 (+1.31%)
AMD   163.25 (+1.83%)
NIO   3.81 (-2.06%)
BABA   69.71 (-1.29%)
T   16.07 (-1.05%)
F   12.16 (-0.57%)
MU   121.21 (-0.13%)
GE   155.27 (+1.02%)
CGC   6.95 (-0.43%)
DIS   114.26 (+1.16%)
AMC   2.71 (+9.72%)
PFE   25.87 (-0.15%)
PYPL   64.09 (+0.91%)
XOM   118.78 (-0.75%)
QQQ   431.84 (+0.18%)
AAPL   169.78 (-1.69%)
MSFT   416.30 (+0.64%)
META   503.26 (+0.61%)
GOOGL   154.79 (-0.05%)
AMZN   184.04 (+0.23%)
TSLA   157.27 (-2.61%)
NVDA   871.25 (+1.31%)
AMD   163.25 (+1.83%)
NIO   3.81 (-2.06%)
BABA   69.71 (-1.29%)
T   16.07 (-1.05%)
F   12.16 (-0.57%)
MU   121.21 (-0.13%)
GE   155.27 (+1.02%)
CGC   6.95 (-0.43%)
DIS   114.26 (+1.16%)
AMC   2.71 (+9.72%)
PFE   25.87 (-0.15%)
PYPL   64.09 (+0.91%)
XOM   118.78 (-0.75%)
QQQ   431.84 (+0.18%)
AAPL   169.78 (-1.69%)
MSFT   416.30 (+0.64%)
META   503.26 (+0.61%)
GOOGL   154.79 (-0.05%)
AMZN   184.04 (+0.23%)
TSLA   157.27 (-2.61%)
NVDA   871.25 (+1.31%)
AMD   163.25 (+1.83%)
NIO   3.81 (-2.06%)
BABA   69.71 (-1.29%)
T   16.07 (-1.05%)
F   12.16 (-0.57%)
MU   121.21 (-0.13%)
GE   155.27 (+1.02%)
CGC   6.95 (-0.43%)
DIS   114.26 (+1.16%)
AMC   2.71 (+9.72%)
PFE   25.87 (-0.15%)
PYPL   64.09 (+0.91%)
XOM   118.78 (-0.75%)
QQQ   431.84 (+0.18%)
AAPL   169.78 (-1.69%)
MSFT   416.30 (+0.64%)
META   503.26 (+0.61%)
GOOGL   154.79 (-0.05%)
AMZN   184.04 (+0.23%)
TSLA   157.27 (-2.61%)
NVDA   871.25 (+1.31%)
AMD   163.25 (+1.83%)
NIO   3.81 (-2.06%)
BABA   69.71 (-1.29%)
T   16.07 (-1.05%)
F   12.16 (-0.57%)
MU   121.21 (-0.13%)
GE   155.27 (+1.02%)
CGC   6.95 (-0.43%)
DIS   114.26 (+1.16%)
AMC   2.71 (+9.72%)
PFE   25.87 (-0.15%)
PYPL   64.09 (+0.91%)
XOM   118.78 (-0.75%)

Hologic (HOLX) Competitors

$76.20
-1.34 (-1.73%)
(As of 12:22 PM ET)

HOLX vs. PHG, QGEN, CUTR, GEHC, LH, AVTR, ALNY, COO, GMAB, and BMRN

Should you be buying Hologic stock or one of its competitors? The main competitors of Hologic include Koninklijke Philips (PHG), Qiagen (QGEN), Cutera (CUTR), GE HealthCare Technologies (GEHC), Laboratory Co. of America (LH), Avantor (AVTR), Alnylam Pharmaceuticals (ALNY), Cooper Companies (COO), Genmab A/S (GMAB), and BioMarin Pharmaceutical (BMRN).

Hologic vs.

Koninklijke Philips (NYSE:PHG) and Hologic (NASDAQ:HOLX) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, earnings, profitability, media sentiment, community ranking and analyst recommendations.

In the previous week, Koninklijke Philips had 4 more articles in the media than Hologic. MarketBeat recorded 21 mentions for Koninklijke Philips and 17 mentions for Hologic. Hologic's average media sentiment score of 0.64 beat Koninklijke Philips' score of 0.55 indicating that Koninklijke Philips is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Koninklijke Philips
10 Very Positive mention(s)
4 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Hologic
3 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Hologic has a consensus price target of $87.00, indicating a potential upside of 12.20%. Given Koninklijke Philips' stronger consensus rating and higher possible upside, analysts clearly believe Hologic is more favorable than Koninklijke Philips.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Koninklijke Philips
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Hologic
0 Sell rating(s)
5 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.44

Hologic has lower revenue, but higher earnings than Koninklijke Philips. Koninklijke Philips is trading at a lower price-to-earnings ratio than Hologic, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Koninklijke Philips$19.66B0.96-$503.27M-$0.57-35.81
Hologic$4.03B4.52$456M$2.1136.75

Hologic has a net margin of 12.98% compared to Hologic's net margin of -2.53%. Koninklijke Philips' return on equity of 18.91% beat Hologic's return on equity.

Company Net Margins Return on Equity Return on Assets
Koninklijke Philips-2.53% 14.17% 5.83%
Hologic 12.98%18.91%10.47%

13.7% of Koninklijke Philips shares are held by institutional investors. Comparatively, 94.7% of Hologic shares are held by institutional investors. 1.8% of Hologic shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Hologic received 480 more outperform votes than Koninklijke Philips when rated by MarketBeat users. Likewise, 69.66% of users gave Hologic an outperform vote while only 56.97% of users gave Koninklijke Philips an outperform vote.

CompanyUnderperformOutperform
Koninklijke PhilipsOutperform Votes
372
56.97%
Underperform Votes
281
43.03%
HologicOutperform Votes
852
69.66%
Underperform Votes
371
30.34%

Koninklijke Philips has a beta of 0.88, suggesting that its share price is 12% less volatile than the S&P 500. Comparatively, Hologic has a beta of 1, suggesting that its share price has a similar volatility profile to the S&P 500.

Summary

Hologic beats Koninklijke Philips on 15 of the 18 factors compared between the two stocks.

Get Hologic News Delivered to You Automatically

Sign up to receive the latest news and ratings for HOLX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HOLX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HOLX vs. The Competition

MetricHologicX IndustryMedical SectorNASDAQ Exchange
Market Cap$18.15B$14.56B$4.73B$7.59B
Dividend YieldN/A0.14%5.44%3.96%
P/E Ratio36.7516.32176.6113.93
Price / Sales4.5215.072,473.7189.08
Price / Cash14.4915.4133.1228.20
Price / Book3.793.094.674.26
Net Income$456M$457.38M$99.83M$211.03M
7 Day Performance-1.11%-6.04%-4.36%-4.55%
1 Month Performance2.15%-7.33%-3.17%-2.06%
1 Year Performance-7.84%-7.95%12.55%6.74%

Hologic Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PHG
Koninklijke Philips
2.2122 of 5 stars
$20.64
+0.9%
N/A+14.7%$19.17B$18.17B-36.2169,656
QGEN
Qiagen
4.2299 of 5 stars
$41.97
+1.1%
$51.69
+23.2%
-17.3%$9.58B$1.97B27.745,967
CUTR
Cutera
1.186 of 5 stars
$1.61
+5.2%
$14.75
+816.1%
-90.1%$32.11M$230.18M-0.22540Gap Down
GEHC
GE HealthCare Technologies
4.0626 of 5 stars
$86.94
-0.9%
$93.92
+8.0%
+4.6%$39.67B$19.55B28.7951,000Upcoming Earnings
LH
Laboratory Co. of America
4.6753 of 5 stars
$210.05
0.0%
$243.50
+15.9%
-11.3%$17.67B$12.16B44.9867,000Dividend Announcement
AVTR
Avantor
4.285 of 5 stars
$25.86
+0.7%
$26.29
+1.6%
+19.4%$17.54B$6.97B53.8814,500Short Interest ↑
ALNY
Alnylam Pharmaceuticals
4.391 of 5 stars
$155.90
-0.1%
$216.12
+38.6%
-27.6%$19.64B$1.83B-43.792,100Analyst Upgrade
COO
Cooper Companies
3.823 of 5 stars
$98.92
+0.3%
$109.48
+10.7%
-1.5%$19.66B$3.59B67.6415,000Short Interest ↓
GMAB
Genmab A/S
3.6626 of 5 stars
$29.97
+0.4%
$48.50
+61.8%
-29.0%$19.80B$2.39B31.222,204Short Interest ↑
BMRN
BioMarin Pharmaceutical
4.6204 of 5 stars
$88.98
+1.9%
$107.61
+20.9%
-7.6%$16.79B$2.42B101.113,401Insider Selling
News Coverage

Related Companies and Tools

This page (NASDAQ:HOLX) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners